Nasal In Situ Gelling Systems for Enhanced Delivery of Loratadine: Recent Developments and Future Perspectives

1. Introduction 1.1 Background of Nasal Drug Delivery 1.2 Overview of Loratadine 1.3 Importance of In Situ Gelling Systems 2. Mechanism of Nasal In Situ Gelling 2.1 Gelling Agents and Polymers 2.2 Mucoadhesion and Retention 2.3 Factors Affecting Gel Formation 3. Advantages of Nasal Delivery 3.1 Improved Bioavailability 3.2 Rapid Onset of Action 3.3 Non-Invasive Administration 4. Formulation Strategies for Loratadine 4.1 Choice of Polymers 4.2 Optimization Techniques 4.3 Stability and Storage Considerations 5. Recent Developments in the Field 5.1 Novel Polymers and Technologies 5.2 Clinical Studies and Results 5.3 Regulatory Challenges and Solutions 6. Challenges and Limitations 6.1 Physiological Barriers to Absorption 6.2 Patient Compliance Issues 6.3 Limitations in Current Research 7. Future Perspectives and Innovations 7.1 Emerging Technologies in Formulation 7.2 Potential for Combination Therapies 7.3 Long-term Market Potential 8. Conclusion 8.1 Summary of Key Findings 8.2 Implications for Future Research 8.3 Final Thoughts on Nasal Gelling Systems